Entity
USPTO Category A Patent Bar Admission Expansion (Biomedical Science)
The USPTO expanded its Category A patent bar admission criteria to include Biomedical Science degrees, broadening automatic eligibility for the patent bar exam. This is part of a broader pattern of USPTO procedural modernization relevant to IP practitioners and biotech patent strategy.
Importance: 35%Confidence: 80%Mentions: 1Updated: August 19, 2026
## Overview
The United States Patent and Trademark Office published a Federal Register Notice on Tuesday, August 11, 2026, announcing administrative updates to the General Requirements Bulletin (GRB), moving Biomedical Science from Category B to Category A degree status for patent bar exam eligibility (IPWatchdog, August 12).
## Details
The GRB outlines the scientific and technical qualifications required for admission to the USPTO registration examination — the prerequisite for practicing patent law before the Office. Category A degrees automatically qualify applicants to sit for the patent bar exam, while Category B degrees require additional coursework or evaluation. By reclassifying Biomedical Science into Category A, the USPTO broadens the pool of applicants who can qualify without extra hurdles (IPWatchdog, August 12).
## Why It Matters
This administrative change has direct strategic relevance for IP attorneys, law firms building biotech/pharma patent practices, and biomedical science graduates considering patent law careers. It comes amid a broader wave of USPTO procedural changes (USPTO ASAP! AI patent search pilot, USPTO SMED guidance update, USPTO design patent modernization for GUIs/VR/AR) and a stated policy environment focused on patent system modernization and expanding qualified practitioner pools ahead of anticipated biotech and AI patent filing surges. Track for related GRB category changes and impacts on patent bar demographics.
## Related Entities
General Requirements Bulletin, USPTO SMED Guidance Update, USPTO Design Patent Modernization, Patent Friction Index.